Effects of aspirin on number, activity and inducible nitric oxide synthase of endothelial progenitor cells from peripheral blood

Acta Pharmacologica Sinica

Volumn 27, Issue 4, 2006, Pages 430-436

  Chen, Tu Gang ^a   Chen, Jun Zhu ^a   Xie, Xu Dong ^a  

^a ZHEJIANG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

Aspirin; Cell adhesion; Cell count; Cell division; Cell movement; Endothelial progenitor cells; Physiologic neovascularization

Indexed keywords

1,1 DIOCTADECYL 3,3,3,3 TETRAMETHYLINDOCARBOCYANINE; 3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; ACETYLSALICYLIC ACID; CYANINE DYE; FIBRONECTIN; FLUORESCENT DYE; INDUCIBLE NITRIC OXIDE SYNTHASE; LOW DENSITY LIPOPROTEIN; UNCLASSIFIED DRUG;

ADULT; ANGIOGENESIS; ARTICLE; BIOASSAY; BLOOD; CELL ACTIVITY; CELL ADHESION; CELL COUNT; CELL CULTURE; CELL DIVISION; CELL MIGRATION; CELL MOTION; CELL PROLIFERATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; DENSITY GRADIENT CENTRIFUGATION; DIAGNOSTIC KIT; ENDOTHELIUM CELL; ENDOTHELIUM STEM CELL; HUMAN; HUMAN CELL; IN VITRO STUDY; LECTIN BINDING; MODIFIED BOYDEN CHAMBER ASSAY; MTT ASSAY; NORMAL HUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; STEM CELL; TIME; WESTERN BLOTTING;

ADULT; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ASPIRIN; CELL ADHESION; CELL MOVEMENT; CELL PROLIFERATION; CELL SEPARATION; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; LEUKOCYTES, MONONUCLEAR; NEOVASCULARIZATION, PHYSIOLOGIC; NITRIC OXIDE SYNTHASE TYPE II; STEM CELLS;

EID: 33645241677     PISSN: 16714083     EISSN: 17457254     Source Type: Journal    
DOI: 10.1111/j.1745-7254.2006.00298.x     Document Type: Article

References (34)

1. Awtry EH Loscalzo J. Aspirin. Circulation 2000 101 1206 15.
2. Weissmann G. Aspirin. Sci Am 1991 264 84 90.
3. Mehta JL. Salutary effects of aspirin in coronary artery disease are not limited to its platelet inhibitory effects. Clin Cardiol 1998 21 879 84.
4. Guo X Chen LW Liu WL Guo ZG. High glucose inhibits expression of inducible and constitutive nitric oxide synthase in bovine aortic endothelial cells. Acta Pharmacol Sin 2000 21 325 8.
5. Natarajan R Jones DG Fisher BJ Wallace TJ Ghosh S Fowler Iii AA. Hypoxia inducible factor-1: regulation by nitric oxide in posthypoxic microvascular endothelium. Biochem Cell Biol 2005 83 597 607.
6. Hill JM Zalos G Halcox JP Schenke WH Waclawiw MA Quyyumi AA et al. Circulating endothelial progenitor cells, vascular function, and cardiovascular risk. N Engl J Med 2003 348 593 600.
7. Kalka C Masuda H Takahashi T Kalka-Moll WM Silver M Kearney M et al. Transplantation of ex vivo expanded endothelial progenitor cells for therapeutic neovascularization. Proc Natl Acad Sci USA 2000 97 3422 7.
8. Chen JZ Zhu JH Wang XX Zhu JH Xie XD Sun J et al. Effects of homocysteine on number and activity of endothelial progenitor cells from peripheral blood. J Mol Cell Cardiol 2004 36 233 9.
9. Vasa M Fichtlscherer S Aicher A Adler K Urbich C Martin H et al. Number and migratory activity of circulating endothelial progenitor cells inversely correlate with risk factors for coronary artery disease. Circ Res 2001 89 E1 E7.
10. Walter DH Rittig K Bahlmann FH Kirchmair R Silver M Murayama T et al. Statin therapy accelerates reendothelialization: a novel effect involving mobilization and incorporation of bone marrow-derived endothelial progenitor cells. Circulation 2002 105 3017 24.
11. Tepper OM Galiano RD Capla JM Kalka C Gagne PJ Jacobowitz GR et al. Human endothelial progenitor cells from type II diabetics exhibit impaired proliferation, adhesion, and incorporation into vascular structures. Circulation 2002 106 2781 6.
12. Reyes M Dudek A Jahagirdar B Koodie L Marker PH Verfaillie CM. Origin of endothelial progenitors in human postnatal bone marrow. J Clin Invest 2002 109 337 46.
13. Murayama T Tepper OM Silver M Ma H Losordo DW Isner JM et al. Determination of bone marrow-derived endothelial progenitor cell significance in angiogenic growth factor-induced neovascularization. Exp Hematol 2002 30 967 72.
14. Suzuki T Nishida M Futami S Fukino K Amaki T Aizawa K et al. Neoendothelialization after peripheral blood stem cell transplantation in humans. A case report of a Tokaimura nuclear accident victim. Cardiovasc Res 2003 58 487 92.
15. Murohara T Ikeda H Duan J Shintani S Sasaki K Eguchi H et al. Transplanted cord blood-derived endothelial precursor cells augment postnatal neovascularization. J Clin Invest 2000 105 1527 36.
16. Schatteman GC Hanlon HD Jiao C Dodds SG Christy BA. Bloodderived angioblasts accelerate blood-flow restoration in diabetic mice. J Clin Invest 2000 106 571 8.
17. Kocher AA Schuster MD Szabolcs MJ Takuma S Burkhoff D Wang J et al. Neovascularization of ischemic myocardium by human bone-marrow derived angioblasts prevents cardiomyocyte apoptosis, reduces remodeling and improves cardiac function. Nat Med 2001 7 430 6.
18. Roth GJ Majerus PW. The mechanism of the effect of aspirin in human platelets. J Clin Invest 1975 56 624 32.
19. Lecomte M Laneuville O Ji C DeWitt DL Smith WL. Acetylation of human prostaglandin endoperoxide synthase-2 (cyclooxygenase-2) by aspirin. J Biol Chem 1994 269 13207 15.
20. Bernhardt J Rogalla K Luscher TF Buhler FR Resink TJ. Acetylsalicylic acid, at high concentrations, inhibits vascular smooth muscle cell proliferation. J Cardiovasc Pharmacol 1993 21 973 6.
21. Kip1. Circulation 2000 102 2124 30.
22. Oberle S Polte T Abate A Podhaisky HP Schroder H. Aspirin increases ferritin synthesis in endothelial cells. Circ Res 1998 82 1016 20.
23. Moschos CB Lahiri K Peter A Jesrani MU Regan TJ. Effect of aspirin upon experimental coronary and non-coronary thrombosis and arrhythmia. Am Heart J 1972 84 525 30.
24. Kharbanda RK Walton B Allen M Klein N Hingorani AD MacAllister RJ et al. Prevention of inflammation induced endothelial dysfunction. Circulation 2002 105 2600 4.
25. Husain S Andrews NP Mulcahy D Panza JA Quyyumi AA. Aspirin improves endothelial dysfunction in atherosclerosis. Circulation 1998 97 716 20.
26. Ranganathan S Joseph J Mehta JL. Aspirin inhibits human coronary artery endothelial cell proliferation by upregulation of p53. Biochem Biophys Res Commun 2003 301 143 6.
27. Levine AJ. p53, the cellular gatekeeper for growth and division. Cell 1997 88 323 31.
28. La Thangue NB. E2F and the molecular mechanisms of early cell-cycle control. Biochem Soc Trans 1996 24 54 9.
29. Katsuyama K Shichiri M Kato H Imai T Marumo F Hirata Y. Differential inhibitory actions by glucocorticoid and aspirin on cytokine-induced nitric oxide production in vascular smooth muscle cells. Endocrinology 1999 140 2183 90.
30. Dimmeler S Aicher A Vasa M Mildner-Rihm C Adler K Tiemann M et al. HMG-CoA reductase inhibitors (statins) increase endothelial progenitor cells via the P13-kinase/Akt pathway. J Clin Invest 2001 108 391 7.
31. Vasa M Fichtlscherer S Adler K Aicher A Martin H Zeiher AM et al. Increase in circulating endothelial progenitor cells by statin therapy in patients with stable coronary artery disease. Circulation 2001 103 2885 90.
32. Mehta JL Li DY. Inflammation in ischemic heart disease; response to tissue injury or a pathogenetic villain. Cardiovasc Res 1999 43 291 9.
33. Kinlay S Selwyn AP Libby P Ganz P. Inflammation, the endothelium, and the acute coronary syndromes. J Cardiovasc Pharmacol 1998 32 Suppl 3 S62 S66.
34. Antiplatelet Trialists' Collaboration. Prevention of death, myocardial infarction and stoke by antiplatelet therapy: collaborative meta-analysis of 266 trials involving 200,000 patients at high risk of occlusive vascular events. Br Med J 2002 324 71 86.